Camelot Portfolios, LLC Novartis Ag Transaction History

Camelot Portfolios, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 25, 2019	SELL	$75.32 - $86.15 $757,945 - $866,927	-10,063 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$73.66 - $82.02 $9,060 - $10,088	123 Added 1.24%	10,063 $863,000
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $7,229 - $8,362	-108 Reduced 1.07%	9,940 $856,000
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $54,784 - $61,915	-844 Reduced 7.75%	10,048 $759,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $17,879 - $21,374	-254 Reduced 2.28%	10,892 $881,000

Q4 2017 Feb 06, 2018	BUY	$72.33 - $77.64 $1,084 - $1,164	15 Added 0.13%	11,146 $936,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $825,252 - $860,092	11,131	11,131 $956,000

1,350

140M

1.15M

866K

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

Stay updated on Camelot Portfolios, LLC with notifications on news.